Robert Paul Harris

Robert Paul Harris discloses dealings in Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) to SEDI. We count 11 filings; the first trade dates from 11 May 2017 and the latest from 30 June 2020.

Every open-market trade on record is a purchase: 10 purchases worth €28k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2020 alone, the filings show 10 purchases and no sales.

Half of the purchases are above €2,398 and half below. The 10 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The latest filing, published on 2 July 2020, reports an open-market purchase of €3,625 in Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.). Typically, a trade is published a median of 4 days after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.